Loading…

Fsk and IBMX inhibit proliferation and proapoptotic of glioma stem cells via activation of cAMP signaling pathway

Objective We aimed to find out the underlying mechanism of forskolin (Fsk) and 3‐isobutyl‐1‐methylxanthine (IBMX) on glioma stem cells (GSCs). Methods The expression of cAMP‐related protein CREB and pCREB as well as apoptosis‐related proteins were detected through Western blot analysis. The level of...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cellular biochemistry 2019-01, Vol.120 (1), p.321-331
Main Authors: Lv, Peng, Wang, Weiyao, Cao, Zhiyou, Zhao, Donghai, Zhao, Guifang, Li, Dailin, Qi, Ling, Xu, Junjie
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective We aimed to find out the underlying mechanism of forskolin (Fsk) and 3‐isobutyl‐1‐methylxanthine (IBMX) on glioma stem cells (GSCs). Methods The expression of cAMP‐related protein CREB and pCREB as well as apoptosis‐related proteins were detected through Western blot analysis. The level of proliferation and growth rate of human GSCs was measured through thiazolyl blue tetrazolium bromide assay and stem cells forming sphere assay. The apoptosis‐related gene expression was measured through reverse transcription‐polymerase chain reaction. Results cAMP signaling pathway was activated in GSCs with Fsk‐IBMX administration. Fsk‐IBMX could inhibit the proliferation as well as invasion and promote the apoptosis of U87 cells. Besides, U0126 could inhibit MAPK signaling pathway to increase the sensitivity of GSCs to cAMP signaling pathway. As a result, Fsk‐IBMX combined with U0126 had more negative effect on GSCs. Conclusions The relationship of cAMP and MAPK signaling pathway in GSCs may provide a potential therapeutic strategy in glioma. The relationship of cAMP and MAPK signaling pathway in GSCs may provide a potential therapeutic strategy in glioma.
ISSN:0730-2312
1097-4644
DOI:10.1002/jcb.27364